Anti-RNA polymerase III antibody in lupus patients with proteinuria. Issue 4 (April 2019)

• Record Type: Journal Article
• Authors: Liao, Hsien-Tzung; Tung, Hsiang-Yuen; Tsai, Chang-Youh
• Is Part Of: Journal of the Chinese Medical Association. Volume 82:Issue 4(2019)
• Publication Date: 2019-04
• Subjects: Anti-RNA polymerase III (RNAP3) antibody -- Biomarker -- Disease activity -- Lupus; Medicine -- Periodicals; 610.5
• DOI: 10.1097/JCMA.0000000000000061
• Languages: English
• ISSNs: 1726-4901

Abstract

Abstract : Background: To investigate the relationship between serum anti-ribonucleic acid polymerase III (anti-RNAP3) autoantibodies (Abs) and proteinuria severity in lupus patients. Methods: Serum antibodies reacting with anti-RNAP3 were measured in 49 systemic lupus erythematosus (SLE) patients (29 cases of SLE with proteinuria and 20 cases of SLE without proteinuria) and 10 healthy controls (HCs). For the patients, we recorded demographic data, daily urinary protein loss, serum anti-double strand deoxyribonucleic acid (anti-ds-DNA) antibodies, serum creatinine (Cr), estimated glomerular filtrating rate (eGFR), complement 3 (C3), and C4. Results: Fewer anti-RNAP3 antibodies were found in the SLE patients than in the HCs ( p = 0.061). In the SLE with proteinuria group, positive correlations were observed among anti-RNAP3 antibodies and daily urinary protein loss, serum C3, C4, and eGFR, and negative correlations were observed between anti-RNAP3-Abs and anti-ds-DNA-Abs and serum Cr levels. However, these correlations were nonsignificant ( p > 0.05). Conclusion: This study demonstrated the possible role of anti-RNAP3 antibodies in SLE patients with proteinuria, as evidenced by their positive and negative relationships with daily urinary protein loss, eGFR, C3, C4, serum Cr, and anti-ds-DNA-Abs. Although these correlations were nonsignificant, our study builds a foundation for future tailored studies, and more in-depth studies with larger samples are warranted to provide more information.